Rate My Professor Sinead Delany-Moretlwe

Professor Sinead Delany-Moretlwe is the Director of Research at the Wits Reproductive Health and HIV Institute (Wits RHI) and a Full Professor of Global Health and Infectious Diseases at the University of the Witwatersrand. She holds the degrees MBBCh, PhD and DTM&H. Her research focuses on the intersection of sexual and reproductive health and infectious diseases, with emphasis on generating evidence to inform policy and practice in high-burden settings. Professor Delany-Moretlwe has played a leading role in the development of novel HIV prevention technologies and served as protocol chair of a landmark phase III clinical trial of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in women, which contributed to its licensure in several countries. She has also led studies evaluating HPV screening and vaccination strategies, particularly among people living with HIV, and is Chief Investigator of an NHMRC-funded population-level study assessing the impact of one- and two-dose HPV vaccination in South Africa. Her current work includes prevention and control of curable sexually transmitted infections, with focus on clinical trials of new treatments and vaccine candidates for gonorrhoea.

Professor Delany-Moretlwe collaborates widely with local and international partners and serves on several South African and World Health Organization advisory committees, including the WHO PDVAC and the WHO HIV, Hepatitis, and STIs Scientific and Technical Advisory Committee. She is also a Co-Principal Investigator of the HIV Prevention Trials Network.